ArticleCancer immunology research2025

Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid Tumors.

Stacey X Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.